DealTranscripta Bio, a Palo Alto-based AI-driven neurology drug discovery company, raised $24 million in a follow-on financing round with participation from Mayo Clinic, JAZZ Venture Partners, and BlueYard Capital.
More on VCNewsDaily →
OTHER
07/25/2026
TidalSense, a Cambridge, UK-based AI respiratory diagnostics company,...
Skyfall AI, a San Francisco-based autonomous enterprise AI platform,...
Omio, a Berlin-based AI multimodal travel platform, raised $10 million in...
Tracksuit, an Auckland, New Zealand-based brand-tracking software...
SceniX, a US-based robotics simulation startup, was acquired for an...
Arpalus, a Tel Aviv, Israel-based computer-vision shelf-intelligence...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
